Daniel H. White, President and CEO at Clearside Biomedical, Inc. (CLSD), sold 8,000 shares at $7.78 ($63K) on 2017-06-13, disclosed to the SEC on 2017-06-14.
Scheduled sale ($63k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.78 | 400 | $3K | 4.9% |
| 2 | $7.78 | 3,600 | $28K | 44.4% |
| 3 | $7.99 | 400 | $3K | 5.1% |
| 4 | $7.99 | 3,600 | $29K | 45.6% |
| Total | $7.88 avg | 8,000 | $63K | 100% |
| Filing → |
| CLSD | SELL | 2017-09-11 | $121K | — | Filing → |
| CLSD | SELL | 2017-07-21 | $78K | — | Filing → |
| CLSD | SELL | 2017-05-19 | $67K | — | Filing → |